HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suayib Yalcin Selected Research

Disease Progression

3/2024Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
1/2019Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP).
1/2013Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase III 'Stop and Go' study results--a Turkish Oncology Group Trial.
11/2011Nilotinib in advanced gastrointestinal stromal tumors after imatinib and sunitinib therapy.
11/2010Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suayib Yalcin Research Topics

Disease

41Neoplasms (Cancer)
03/2024 - 12/2002
14Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 03/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 01/2002
10Neoplasm Metastasis (Metastasis)
03/2024 - 12/2002
8Adenocarcinoma
01/2021 - 01/2002
5Disease Progression
03/2024 - 11/2010
5Colonic Neoplasms (Colon Cancer)
05/2023 - 01/2019
4Malnutrition (Nutritional Deficiencies)
04/2024 - 11/2019
4Stomach Neoplasms (Stomach Cancer)
12/2023 - 09/2009
4Carcinoma (Carcinomatosis)
01/2021 - 01/2005
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2020 - 05/2011
3Inflammation (Inflammations)
04/2024 - 04/2021
3Hepatocellular Carcinoma (Hepatoma)
11/2023 - 01/2020
3Rectal Neoplasms (Rectal Cancer)
05/2023 - 01/2012
3Liver Neoplasms (Liver Cancer)
01/2023 - 01/2020
3Renal Cell Carcinoma (Grawitz Tumor)
08/2022 - 01/2019
2Breast Neoplasms (Breast Cancer)
05/2023 - 01/2013
2Acute Kidney Injury (Acute Renal Failure)
01/2023 - 06/2022
2Cholangiocarcinoma
11/2022 - 01/2004
2Hypoalbuminemia
09/2022 - 01/2022
2Thyroid Neoplasms (Thyroid Cancer)
01/2015 - 01/2015
2medullary Thyroid cancer
01/2015 - 01/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2013 - 01/2007
1Exanthema (Rash)
03/2024
1Stomatitis
03/2024
1Vascular Malformations
03/2024
1Microsatellite Instability
12/2023
1Cachexia
01/2023
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2023
1Thromboembolism
09/2021
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Pulmonary Embolism
01/2021
1COVID-19
07/2020

Drug/Important Bio-Agent (IBA)

8Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 11/2003
7Immune Checkpoint InhibitorsIBA
02/2024 - 01/2022
6PlatinumIBA
11/2023 - 01/2004
6Cisplatin (Platino)FDA LinkGeneric
07/2015 - 01/2004
5Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023 - 01/2013
5Capecitabine (Xeloda)FDA Link
01/2023 - 01/2013
4Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2022
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 12/2014
4Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 03/2003
4Docetaxel (Taxotere)FDA Link
07/2015 - 01/2002
3AlbuminsIBA
04/2024 - 01/2022
3Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2023
3Bevacizumab (Avastin)FDA Link
11/2023 - 01/2013
3Leucovorin (Folinic Acid)FDA Link
01/2019 - 11/2003
3Sunitinib (Sutent)FDA Link
01/2015 - 05/2011
3Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 05/2011
2Panitumumab (Vectibix)FDA Link
03/2024 - 12/2014
2Tyrosine Kinase InhibitorsIBA
02/2024 - 01/2015
2NivolumabIBA
11/2023 - 09/2021
2human ERBB2 proteinIBA
05/2023 - 01/2021
2ThrombospondinsIBA
08/2022 - 12/2021
2GemcitabineFDA Link
03/2020 - 08/2014
2Monoclonal AntibodiesIBA
01/2019 - 12/2014
2Cetuximab (Erbitux)FDA Link
12/2014 - 07/2010
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2013 - 04/2011
2nilotinibFDA Link
11/2011 - 05/2011
2Peptides (Polypeptides)IBA
04/2011 - 01/2007
2Angiogenesis InhibitorsIBA
04/2011 - 01/2007
1Serum AlbuminIBA
04/2024
1Sirolimus (Rapamycin)FDA Link
03/2024
1TOR Serine-Threonine KinasesIBA
03/2024
1sotorasibIBA
03/2024
1pembrolizumabIBA
12/2023
1atezolizumabIBA
11/2023
1folfirinoxIBA
11/2023
1tributyl phosphate (TBP)IBA
07/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2023
1Caveolin 1IBA
05/2023
1AntigensIBA
04/2023
1Antineoplastic Agents (Antineoplastics)IBA
01/2023
1Discoidin Domain ReceptorsIBA
01/2023
1Complement System Proteins (Complement)IBA
02/2022
1GlobulinsIBA
01/2022
1AzoxymethaneIBA
12/2021
1Circulating Tumor DNAIBA
12/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2021
1Axitinib (AG 013736)IBA
09/2021
1Tumor Biomarkers (Tumor Markers)IBA
04/2021
1Trastuzumab (Herceptin)FDA Link
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
03/2020

Therapy/Procedure

26Drug Therapy (Chemotherapy)
04/2024 - 01/2002
21Therapeutics
11/2023 - 11/2010
7Immunotherapy
01/2023 - 08/2014
4Adjuvant Chemotherapy
03/2024 - 01/2019
4Radiotherapy
05/2023 - 01/2005
3Metastasectomy
05/2023 - 01/2015
3Chemoradiotherapy
01/2021 - 01/2005
2Adjuvant Chemoradiotherapy
12/2023 - 01/2012
2Neoadjuvant Therapy
05/2023 - 11/2013
2Aftercare (After-Treatment)
04/2022 - 01/2020
1Pancreaticoduodenectomy
11/2023
1Precision Medicine
11/2022
1Inappropriate Prescribing
06/2022
1Polypharmacy
06/2022
1Preoperative Exercise
04/2022
1Gastrectomy
01/2021
1Palliative Care (Palliative Therapy)
07/2020